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Abstract
Background: The ability of Mycobacterium tuberculosis to survive and replicate in macrophages is
crucial for the mycobacterium's ability to infect the host and cause tuberculosis. To identify
Mycobacterium tuberculosis genes involved in survival in macrophages, a library of non-pathogenic
Mycobacterium smegmatis bacteria, each carrying an individual integrated cosmid containing M.
tuberculosis H37Rv genomic DNA, was passed through THP-1 human macrophages three times.
Results: Two of the clones recovered from this enrichment process, sur2 and sur3, exhibited
significantly increased survival relative to wild-type bacteria. In coinfection experiments, the ratio
of sur2 colonies to wild-type colonies was 1:1 at 0 hours but increased to 20:1 at 24 hours post
phagocytosis. The ratio of sur3 colonies to wild-type colonies was 1:1 at 0 hours and 5:1 at 24
hours. The M. tuberculosis ORFs responsible for increased survival were shown to be Rv0365c for
the sur2 clone and Rv2235 for the sur3 clone. These ORFs encode proteins with as-of-yet
unknown functions.
Conclusions: We identified two M. tuberculosis ORFs which may be involved in the ability of
tubercle bacilli to survive in macrophages.
Background
Today, an estimated one-third of the world's population
is infected with Mycobacterium tuberculosis, the causa-
tive agent of tuberculosis [1,2], and tuberculosis causes
about 2 million deaths annually [1,2]. Many aspects of
the interactions between M. tuberculosis and its human
host remain unclear. Not only is this bacterium able to
evade the defenses of the host's immune system, it is also
able to persist in the body for years and may reactivate to
cause disease decades after the initial infection. A better
understanding of the interaction between M. tuberculo-
sis and its human host is critical to developing new strat-
egies to control the tuberculosis epidemic.
A key feature of the pathogenicity of M. tuberculosis is its
ability to evade the antimicrobial processes of the macro-
phage and replicate intracellularly. Mycobacteria enter
macrophages primarily by conventional receptor-medi-
ated phagocytic pathways [3]. Following phagocytosis,
phagosomes containing viable tubercle bacilli fail to
acidify, apparently because of failure to insert a proton-
ATPase pump into the phagosomal membrane [4–6].
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phagosome-lysosome fusion is blocked and the myco-
bacteria-containing vacuoles end up with an internal pH
of about 6 and markers of phagosomes and early and late
endosomes [7–11]. The mycobacterial genes responsible
for these processes are largely unknown.
One method for identifying bacterial genes involved in
pathogenesis is to express these genes in a nonpathogen-
ic host and isolate bacteria with increased virulence. This
technique was first used to identify a gene that enables
Yersinia pseudotuberculosis to invade HEp-2 cells [12].
In these studies, Escherichia coli bacteria expressing Y.
pseudotuberculosis genes were used to infect HEp-2
cells. Only E. coli bacteria expressing the Y. pseudotu-
berculosis inv gene were able to invade the animal cells
[12]. Using a similar approach, Arruda et al. [13] identi-
fied an M tuberculosis gene responsible for invasion of
HeLa cells. We have previously used a similar technique
to identify M. leprae genes involved in intracellular sur-
vival [14]. That is, by expressing M. leprae genes in E. co-
li, we were able to isolate recombinant bacteria that
exhibited increased resistance to killing by murine bone-
marrow derived macrophages [14].
A similar approach was used by Wei et al [15] to isolate
21 Mycobacterium smegmatis recombinant clones that
displayed a greater than 2-fold enhancement in survival
after 48 hours. M. smegmatis is a fast-growing, nonpath-
ogenic species of Mycobacterium in which M. tuberculo-
sis genes can be efficiently expressed [16–18]. An in
depth analysis of one recombinant clone revealed that M.
smegmatis recipients carrying the M. tuberculosis eis
gene on an extrachromosomal multicopy plasmid dis-
played 2.4- to 5.3-fold greater survival in U937 macro-
phages than wild-type M. smegmatis bacteria at 24 to 48
hours post-infection [15]. The 42-kDa eis gene product
has been shown to be associated with the mycobacterial
cell surface and is released into extracellular medium,
but its precise function is not yet known [19].
In the studies reported here, we used a similar enrich-
ment scheme to identify two additional recombinant M.
smegmatis clones, sur2 and sur3, that demonstrated en-
hanced survival during infections of THP-1 human
monocyte-derived macrophages. The M. tuberculosis
ORFs responsible for increased survival were shown to
be Rv0365c for the sur2 clone and Rv2235 for the sur3
clone. These ORFs encode proteins with as-of-yet un-
known functions.
Results
Cosmids carrying M. tuberculosis genes [20] were elec-
troporated into M. smegmatis LR222 to create a library
of M. smegmatis transformants, each of which carries a
pYUB178::H37Rv cosmid integrated into its chromo-
some. The library was generated from about 4000 inde-
pendent transformants. This represents about 20 M.
tuberculosis genome-equivalents given that ~225 cos-
mids contain one genome-equivalent of M. tuberculosis
[20].
To enrich for clones with increased survival in human
macrophages, the library was passed through THP-1
macrophages as shown schematically in Figure 1. THP-1
is a human monocyte-derived macrophage cell line [21]
and wild-type M. smegmatis bacteria are rapidly killed
by THP-1 macrophages [22]. After three rounds of en-
richment, the resulting clones were analyzed individual-
ly by Southern blot to evaluate the number of different
clones present as previously described [20]. Out of the
3000 colonies recovered, genomic DNAs from the bacte-
ria of 90 randomly chosen colonies were digested with
PstI and hybridized with the pYUB178 vector. Strains
carrying different cosmids should exhibit a different pat-
tern of hybridizing bands because of the presence of dif-
ferent M. tuberculosis H37Rv inserts. Two clones,
designated sur2 and sur3, were each present three times
and were chosen for further study. The remaining 84
clones each displayed unique patterns.
As a first step in the analysis of the sur2 clone, the time
course of its survival in THP-1 macrophages was deter-
mined by infecting THP-1 macrophages, lysing the in-
fected macrophages at various times after phagocytosis,
and enumerating viable intracellular bacteria by plating
on solid medium. Both parental and the sur2 bacteria
were rapidly killed during the first few hours after phago-
cytosis (Figure 2). The sur2 bacteria appeared to survive
slightly better at the 9 hour time point, but the difference
was not statistically significant.
To compare directly the relative ability of the sur2 and
wild-type bacteria to survive in macrophages, THP-1
macrophages were infected with a mixture of a genetical-
ly marked control strain and the sur2 strain and the sur-
vival of each strain was followed independently as
previously described [22]. The wild-type strain expresses
the xylE gene product, catechol 2,3-dioxygenase, such
that when its colonies are sprayed with catechol, they
turn bright yellow, while wild-type colonies remain
white. In essence, each well of the experiment contains
an internal standard (the wild-type bacteria) to which to
compare the survival of the recombinant bacteria. In ex-
periments in which THP-1 cells were infected at a MOI of
50:1 (results in ~1 phagocytosed M. smegmatis bacteri-
um per macrophage) with a mixture containing equal
numbers of bacteria of the xylE-expressing control strain
and a strain carrying the cosmid vector pYUB178, the ra-
tio of recovered white colonies to yellow colonies was 1:1
BMC Microbiology 2001, 1:26 http://www.biomedcentral.com/1471-2180/1/26at all time points (data not shown). This indicates that
the survival of the xylE-expressing strain was the same
as that of the wild-type and could be used an internal ref-
erence by which to measure the survival of other clones.
In coinfection experiments with xylE-expressing bacte-
ria, both sur2 and sur3 bacteria exhibited increased sur-
vival (Figure 3). Immediately after the 2 hour
phagocytosis period (0 hr time point) the ratio of sur2
colonies to xylE-expressing colonies was 1:1 and by 12
hours it was about 7:1. By 24 hours, the ratio was approx-
imately 20:1. The differences between the ratios at the
zero time point and the subsequent time points were sta-
tistically significant (p < 0.005) for the 9, 12, and 24 hr
time points. The ratio of sur3 colonies to control colonies
increased from 1:1 at time 0 to 4:1 at 12 hours and to 5:1
at 24 hours (p < 0.005).
Because the recombinant clones contain integrated
pYUB178::H37Rv cosmids, the following strategy was
used to isolate cosmids corresponding to those in the
sur2 and sur3 clones. First, genomic DNA from the sur2
clone was digested with PstI, and genomic DNA from the
sur3 clone was digested with BamHI to generate frag-
ments of each integrated cosmid carrying oriE, aph, and
a portion of the M. tuberculosis genomic DNA insert.
The presence of oriE allows the recombinant to replicate
as a plasmid in E. coli. The digestion products were treat-
ed with T4 DNA ligase and transformed into E. coli XL 1-
Blue. Plasmid DNA from the resulting kanamycin-resist-
ant colonies were analyzed by restriction site mapping
and partial sequencing of the M. tuberculosis genomic
DNA insert as described in Materials and Methods. For
the sur2 recombinant, PCR primers were designed to
amplify a 0.8 kb region of the M. tuberculosis insert from
M. tuberculosis genomic DNA for use as a probe in colo-
ny blot experiments. Probing colony blots of the E. coli
(pYUB178::H37Rv) library with the 0.8 kb PCR fragment
led to the isolation of a 4 kb plasmid. This plasmid con-
tained an intact oriE and aph gene, a portion of the inte-
grase gene, and 1.1 kb of M. tuberculosis genomic DNA
(Figure 4). PCR, DNA sequence, and Southern blot data
indicated that the recovered plasmid was the same as the
cosmid integrated in the sur2 genome (data not shown).
For example, sequencing of PCR amplicons of the junc-
tions between the mycobacterial sequences and vector
sequences revealed that the junctions in the recovered
plasmid were identical to those in the sur2 genomic
DNA.
Comparison of the sequence of the cloned 1.1 kb frag-
ment with the M. tuberculosis H37Rv genome sequence
[23] revealed that it contains portions of the Rv0366c
and Rv0365c genes (Figure 4). In the sur2 clone, the
Figure 1
Enrichment procedure.
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Figure 2
Survival of sur2. THP-1 macrophages were infected with bac-
teria containing pYUB178 (hatched) or sur2 bacteria (hori-
zontal stripe). Time zero is defined as immediately after the
phagocytosis interval. Percent survival at time × was calcu-
lated by dividing the number of CFUs recovered at time × by
the number of CFU recovered at time zero and multiplying
by 100.
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BMC Microbiology 2001, 1:26 http://www.biomedcentral.com/1471-2180/1/26amino-terminal 970 bp of the 1128 bp Rv0365c ORF is
fused to 14 bp from the pYUB178 vector to generate an
ORF encoding 328 amino acids (aa), compared to 376 aa
encoded by the full-length Rv0365c ORF. The insert also
contains 104 bp of the Rv0366c ORF fused to 220 bp of
the L5 integrase ORF. This ORF could encode a 108 aa
protein which contains the 73 amino-terminal amino ac-
ids of the 344 aa L5 integrase protein fused to the 34 car-
boxyl-terminal amino acids of the Rv0366c ORF.
To determine if the Rv0365c gene was responsible for
the increased survival of sur2 bacteria, the full-length M.
tuberculosis Rv0365c ORF as well as a truncated ORF
similar to that present in the insert in the sur2 clone were
subcloned into the pHIP vector downstream of the M. tu-
berculosis hsp65 promoter. The truncated ORF con-
tained the 969 bp of Rv0365c present in the sur2 insert
followed by a stop codon but did not contain the 5 amino
acids corresponding to the vector contribution to the
ORF. In coinfection experiments, the ratio of M. smeg-
matis bacteria expressing the full-length Rv0365c ORF
to xylE-expressing wild-type bacteria was 1:1 at time zero
and increased to approximately 10:1 at 12 hours and to
11:1 at 24 hours (Figure 5). The clone expressing the
truncated Rv0365c ORF exhibited slightly less, but not
statistically significantly different, increased survival (1:1
at time zero, 8.6:1 at 24 hrs).
To investigate the difference in survival at 24 hours of the
full-length Rv0365c ORF expressing bacteria and sur2
bacteria, a strain expressing Rv0365c and xylE was con-
structed and used in THP-1 coinfections with the original
sur2 clone. In this coinfection, the ratio of white (sur2) to
yellow (xylE and Rv0365c expressing) colonies re-
mained 1:1 through 12 hours and then increased to ~3:1
at 24 hrs, consistent with the above-described observa-
tions.
A cosmid corresponding to the one in the sur3 clone was
isolated from the E. coli (pYUB178::H37Rv) library by
probing colony blots with the 4.5 kb BamHI/EcoRl frag-
ment of the M. tuberculosis genomic DNA insert in the
plasmid recovered from the sur3 clone. PCR, DNA se-
quence, and Southern blot data indicated that the recov-
ered cosmid was the same as the cosmid integrated in the
sur3 genome (data not shown). The ~10.7 kb cosmid in
the sur3 chromosome contains a 5.76 kb fragment of M.
tuberculosis H37Rv genomic DNA (Figure 6) [23]. This
region encodes eight potential ORFs designated Rv2233-
Rv2240c as well as the tRNA for valine.
Figure 3
Survival of recombinants relative to wild-type M. smegmatis.
THP-1 macrophages were infected with an equal mixture of
xylE-expressing bacteria and sur2 bacteria (hatched) or sur3
bacteria (horizontal stripe). The ratio of the recovered
white-to-yellow colonies is shown for -2 hours (initial inocu-
lum), 0 hours (immediately after phagocytosis interval), and
at 3, 6, 9, 12, and 24 hours after phagocytosis. The ratios
represent the average of the results of three independent
experiments. Error bars represent the standard deviation in
the ratio of white-to-yellow colonies between experiments.
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Figure 4
Map of the M. tuberculosis H37Rv DNA integrated in the sur2
genome. The integrated 4 kb cosmid is between the two
attachment sites, attL and attR. The 4.4 kb PstI fragment of
sur2 is indicated by the two PstI sites. The 1,106 bp M. tuber-
culosis H37Rv genomic DNA insert contains two ORFs desig-
nated Rv0365c and Rv0366c [Reference 23]. The arrows
indicate the direction of transcription. Arrows are color
coded according to annotations found on the TubercuList
server  [http://genolist.Pasteur.fr/TubercuList/] : light green
(unknown), brown (conserved), yellow (intermediary metab-
olism), light blue (regulatory), gray (virulence), red (informa-
tion pathway), dark green (cell wall process), black (lipid
metabolism), and dark blue (stable RNA).
M. tuberculosis DNA L5 intattL oriE aph attR
Rv0366cRv0365c
PstIPstI
BMC Microbiology 2001, 1:26 http://www.biomedcentral.com/1471-2180/1/26To determine which ORF(s) was responsible for the in-
creased survival exhibited by sur3 bacteria, each ORF
was subcloned individually into the expression vector
pHIP. The two potential operons, Rv2233-Rv2235 and
Rv2238c-Rv2240c, were also subcloned into pHIP. The
recombinant bacteria were examined for survival in the
macrophage in coinfection experiments at 0, 6, and 12
hours post phagocytosis (Figure 7). Each of the recom-
binants tested exhibited a 1:1 ratio of white-to-yellow col-
onies at 0 hours. Two of the recombinants demonstrated
an increase in the ratio of white-to-yellow colonies over
time, while the ratio remained at 1:1 for the other eight
recombinants. One of the two recombinants contained
the potential operon of Rv2233-Rv2235, and the other
contained Rv2235 only. The ratio of white-to-yellow col-
onies for bacteria expressing ORFs Rv2233-Rv2235 was
~2:1 at 6 hours and ~6:1 at 12 hours. For bacteria ex-
pressing Rv2235, the ratio of white-to-yellow colonies
was ~2:1 at 6 hours and >3:1 at 12 hours. The survival of
recombinant bacteria expressing the Rv2235 ORF rela-
tive to wild-type was more directly compared to the rela-
tive survival of sur3 by doing the coinfections in parallel.
The ratios of white-to-yellow for both recombinant bac-
teria and sur3 bacteria were 1:1 at 0 hours, ~5:1 at 12
hours, and >5:1 at 24 hours. The differences in the rela-
tive survival of the three strains were not statistically sig-
nificant.
A PCR fragment containing the M. tuberculosis ORFs
Rv2233, Rv2234, and Rv2235 without the upstream
promoter region, was cloned into the pBPhin vector,
which does not contain a promoter to express the insert-
ed DNA. In coinfections with the xylE-expressing bacte-
ria, the recombinant bacteria containing Rv2233,
Rv2234, and Rv2235 did not exhibit the same increase in
macrophage survival as the sur3 clone (data not shown),
suggesting that the Rv2235 ORF is expressed using sig-
nals upstream of the Rv2233 ORF.
Southern blots of genomic DNA from M. tuberculosis, M.
smegmatis, Mycobacterium leprae, and Mycobacteri-
um avium were probed with Rv0365c and Rv2235.
Rv0365c hybridized to bands in M. tuberculosis, M. avi-
um, and M. smegmatis under high stringency conditions
(data not shown). Rv2235 hybridized to a band in M. tu-
Figure 5
Survival of bacteria expressing ORF Rv0365c. THP-1 macro-
phages were infected with an equal mixture of xylE-express-
ing bacteria and bacteria expressing the full length Rv0365c
ORF under the control of the hsp65 promoter (hatched) or
sur2 bacteria (horizontal stripes). The ratios of white-to-yel-
low colonies represent the average of at least three inde-
pendent experiments. Error bars represent the standard
deviation in the ratio of white-to-yellow colonies between
experiments.
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Figure 6
Map of the M. tuberculosis H37Rv DNA integrated in the sur3
genome. The integrated 10.7 kb cosmid is between the two
attachment sites, attL and attR. The ~7.4 kb BamHl and ~4.5
kb BamHI/EcoRI fragments are indicated by the BamHI and
EcoRI sites. The 5.76 kb fragment of M. tuberculosis H37Rv
genomic DNA contains the 34 bp of DNA upstream of
Rv2233, Rv2233-Rv2240c, and the tRNA for valine [Refer-
ence 23]. The arrows indicate the direction of transcription.
Arrows are color coded according to annotations found on
the TubercuList server  [http://genolist-Pasteur.fr/Tubercu-
List/] : light green (unknown), brown (conserved), yellow
(intermediary metabolism), light blue (regulatory), gray (viru-
lence), red (information pathway). dark green (cell wall proc-
ess), black (lipid metabolism), and dark blue (stable RNA).
BMC Microbiology 2001, 1:26 http://www.biomedcentral.com/1471-2180/1/26berculosis, and under low stringency conditions recog-
nized a band in M. leprae (data not shown).
Database searches revealed that Rv0365c encodes an
~41-kDa protein which displays significant homology
only to a truncated Corynebacterium glutamicum hypo-
thetical protein of unknown function (42% identity in a
296 aa overlap) located upstream of a gene encoding a
fructose-bisphosphate aldolase. Rv2235 encodes a con-
served hypothetical membrane protein of about 30-kDa
and shares a motif with the SURF-1 family of proteins.
The other two ORFs in the putative Rv2233-Rv2235
operon, Rv2233 and Rv2234, share homology with sev-
eral proteins in data base searches. Rv2233 may encode
a putative phosphatase, and Rv2234 may encode a low
molecular weight protein tyrosine phosphatase [23].
Discussion
There are several potential limitations of isolating M. tu-
berculosis genes involved in intracellular survival using
an enrichment procedure. One limitation is that this pro-
tocol is biased towards the recovery of clones with the
greatest increase in survival relative to wild-type [14].
Thus, the recovered clones are not a random collection of
genes involved in intracellular survival and hence the
number of genes involved for survival cannot be calculat-
ed. This approach is also biased towards identifying
genes expressing proteins that directly interfere with the
antimicrobial processes of the macrophage. Some types
of genes involved in resistance to killing, such as genes
that are part of a multi-enzyme pathway, may not be iso-
lated. Also, genes necessary for intracellular survival as
opposed to resistance to killing are not likely to be isolat-
ed.
Two general classes of clones might be recovered follow-
ing enrichment of the M. smegmatis recombinant library
for clones with increased intracellular survival. One type
might be clones that carry M. tuberculosis genes that
confer enhanced resistance to the antimicrobial process-
es of the macrophage. Another type might be clones
whose M. tuberculosis gene products are involved in at-
tachment or invasion or increase phagocytosis. The two
genes that were isolated in the studies reported here con-
fer enhanced resistance rather than increased uptake.
That is, the ratios of bacteria expressing either Rv0365c
or Rv2235 to wild-type bacteria were 1:1 in both the ini-
tial mixture and inside the macrophages at the end of the
phagocytosis period. Differences in survival compared to
wild-type did not become apparent until about 9 hours
post-phagocytosis for bacteria expressing Rv0365c and
about 6 hours post-phagocytosis for those expressing
Rv2235.
In this study, the enrichment process resulted in the iso-
lation of two strains containing small, integrated plas-
mids rather than the expected 30–50 kb cosmids [20].
Small plasmids corresponding to the integrated ones
were present in the original E. coli (pYUB178:H37Rv)
cosmid library. PCR, sequencing, and Southern blot
analysis demonstrated that the plasmid integrated in the
sur2 clone was approximately 4 kb containing 1.1 kb of
M. tuberculosis DNA and the plasmid integrated in the
sur3 clone was approximately 10.7 kb containing about
5.7 kb of M. tuberculosis DNA. Cosmid libraries fre-
quently contain clones without DNA inserts [24], so it is
not too surprising that clones with small DNA fragments
were present in the E. coli library after infection with λ
phage. The small plasmids may have a growth or replica-
tion advantage causing them to be over-represented in
the library following the various amplification steps.
Figure 7
Survival of M. smegmatis LR222 bacteria expressing ORFs in
the sur3 insert. THP-1 macrophages were infected with an
equal mixture of xylE-expressing bacteria and bacteria
expressing one or more of the sur3 ORFs. The ratio of the
recovered white-to-yellow colonies is shown for -2 hours
(initial inoculum), 0 hours (immediately after phagocytosis
interval), and at 6 and 12 hours after phagocytosis. THP-1
macrophages were infected with an equal mixture of xylE-
expressing bacteria and bacteria expressing Rv2233 (first
open column), Rv2234 (first /// lines), Rv2235 (first \\\ lines),
Rv2236c (hatched), Rv2237 (horizontal stripes), Rv2238c
(vertical stripes), Rv2239c (box pattern), Rv2240c (second
open column), Rv2233-Rv2235 (second /// lines), or Rv2238c-
Rv2240c (second \\\ lines). Error bars represent the standard
deviation in the ratio of white-to-yellow colonies between
experiments.
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BMC Microbiology 2001, 1:26 http://www.biomedcentral.com/1471-2180/1/26The ~2 kb deletion of vector DNA in the sur2 clone re-
sults in a fusion of the ORF of the L5 integrase with that
of the M. tuberculosis insert such that the fused ORF en-
codes a protein that contains only the amino-terminal 73
aa of the 344 aa L5 integrase. The observation that the
sur2 clone contains an integrated plasmid corresponding
to the plasmid isolated from the cosmid library suggests
that either a) the hybrid protein retains integrase activi-
ty, b) the plasmid inserted into the attachment site by ho-
mologous recombination between attP and attB, or c) a
functional integrase was provided in trans by a second
cosmid transiently present in the original transformant
or by a gene present in the M. smegmatis LR222 ge-
nome. However, repeated attempts to electroporate the 4
kb plasmid into M. smegmatis LR222 did not generate
any stable kanamycin-resistant transformants (data not
shown). These results suggests that the hybrid protein
does not retain integrase activity, that integration by ho-
mologous recombination into attP is unlikely, and that
provision of integrase activity by an M. smegmatis gene
chromosomal does not occur. The simplest explanation
is that integrase was provided in trans by a second cos-
mid transiently present in the original transformant, and
indeed, M. smegmatis bacteria carrying an integrated
copy of the 4-kb plasmid can be readily isolated following
electroporation of a mixture of the 4-kb plasmid and a
plasmid that expresses integrase (unpublished results).
Data base searches did not reveal any homologies that
could be used to predict functions for the gene products
of ORFs Rv0365c or Rv2235. Rv0365c encodes a hypo-
thetical protein of 376 amino acids which displays signif-
icant homology only to a Corynebacterium glutamicum
hypothetical protein of unknown function (42% identity
in a 296 aa overlap) [23]. Rv2235 encodes a hypothetical
protein of 271 aa with three putative transmembrane do-
mains and which displays significant homology only to
hypothetical protein MLCB1243.32c in M. leprae, to
which it is 74% identical [23,25]. This M. leprae homo-
logue was evident in Southern blot experiments done un-
der low stringency conditions. Rv2235 also contains the
SURF-1 signature sequence [26] and modest homology
to members of the SURF-1 family such as the SURF-1
protein of Caulobacter crescentus (25% identity; 40%
similarity) [27]. SURF-1 proteins are ~33-kDa, integral
membrane proteins whose precise function is not
known. In eukaryotic cells, SURF-1 proteins are involved
in the assembly and maintenance of mitochondrial respi-
ratory chain complexes including cytochrome oxidase
[26,28]. The homology to SURF-1 proteins raises the
possibility that Rv2235 could play a role in resisting the
antimicrobial activities of macrophages by helping to
maintain the stability or function of an important cellu-
lar process, akin to the stabilizing role of chaperonins
during a heat shock.
In addition to the genes described in this report, other
studies with M. smegmatis recombinants and/or mu-
tants have implicated 11 other M. tuberculosis genes in
intracellular survival. Genes identified using enrichment
or screening protocols include Rv2962c and Rv2958c
(probable glucuronsyl transferases), Rv2220 (glutamine
synthetase A1), Rv3913-Rv3914 (thioredoxin, thioredox-
in reductase) and Rv2416c (eis, unknown function)
[14,15,22,29]. By screening insertional mutants of M.
smegmatis, Lagier et al [30] isolated 8 mutants with im-
paired ability to survive in human peripheral blood
monocyte-derived macrophages and identified the M.
tuberculosis gene corresponding the mutated M. smeg-
matis gene for five of them. The genes included: Rv3052c
(probable nrdI) which is postulated to be involved in de-
oxynucleotide production under stressed conditions;
Rv0101 which is a nonribosomal peptide synthetase that
displays strong homology with a Pseudomonas nonri-
bosomal peptide synthetase required for the synthesis of
the pyoveridine, a siderophore involved in iron uptake;
Rv3420c which displays homology with the S18 ribos-
omal protein acetyltransferase which behaves as a heat
shock protein in Chlamydia trachomatis; and Rv0497
and Rv3604c which are hypothetical conserved mem-
brane proteins of unknown function.
It should be noted that these M. tuberculosis genes gen-
erally confer only a limited enhancement of the survival
of M. smegmatis bacteria in the human macrophages.
That is, usually only a few per cent of the recipients are
viable 24 to 48 hours post-infection. This reinforces the
concept that the intracellular survival of a pathogenic
mycobacteria is a complex multifactoral process. The
precise role(s) of any of the identified genes in the intra-
cellular survival of mycobacteria is not yet known, al-
though several of the identified genes have features of
stress response genes. This is not unexpected given the
relatively small enhancements of the survival of the M.
smegmatis recombinants and the numerous environ-
mental stresses encountered in the macrophage. Addi-
tional studies, such as the construction and
characterization of targeted knock-out mutants, will be
needed to determine the roles of the proteins encoded by
these genes in the survival of M. tuberculosis in human
macrophages.
Conclusions
Using an enrichment and screening procedure, two M.
tuberculosis genes, Rv0365c and Rv2235, were identi-
fied that could confer an enhanced ability to survive in
human macrophages to normally susceptible M. smeg-
matis recipients. The functions of these two proteins are
not known. This study brings the number of M. tubercu-
losis genetic loci that have been implicated in enhancing
the intracellular survival of M. smegmatis cells to 13. The
BMC Microbiology 2001, 1:26 http://www.biomedcentral.com/1471-2180/1/26precise role(s) of any of the identified genes in the intra-
cellular survival of mycobacteria remain to be elucidat-
ed.
Materials and methods
Bacterial strains, plasmids, and growth conditions
The bacterial strains and plasmids used in this study are
listed in Table 1. The E. coli strain XL 1-Blue was ob-
tained from Stratagene (La Jolla, Calif). The M. smegma-
tis strain LR222 was obtained from Dr. Jack Crawford,
Tuberculosis and Mycobacteriology Branch, Centers for
Disease Control and Prevention (CDC), Atlanta, GA. The
pYUB178 plasmid and the λ phage library of
pYUB178::H37Rv cosmids were generously provided by
Dr. William Jacobs, Albert Einstein University, New
York, NY [20]. The cosmid library contains 30–50 kb
fragments of M. tuberculosis genomic DNA generated by
partial Sau3A digestion cloned into BclI-digested
pYUB178. In the λ phage library, ~225 cosmids repre-
sent one genome-equivalent of M. tuberculosis [20]. An
E. coli (pYUB178::H37Rv) library was created by infect-
ing E. coli XL1-Blue with the λ phage library. Bacteria
from ~4000 colonies were recovered and pooled, and
cosmid DNA was isolated. The pooled pYUB178::H37Rv
cosmid DNAs were electroporated into M. smegmatis
LR222, and kanamycin-resistant colonies were isolated.
Bacteria from ~4,000 colonies (representing ~20 ge-
nome equivalents) were recovered and pooled to gener-
ate the M. smegmatis (pYUB178::H37Rv) library.
Because the cosmids integrate into the mycobacteri-
ophage L5 attachment site in the M. smegmatis genome,
a single copy of the M. tuberculosis DNA is maintained in
the M. smegmatis transformants [20].
The E. coli (pYUB178::H37Rv) library was grown in Lu-
ria broth (LB) (Difco Laboratories, Detroit, Mich.) con-
taining 50 µg kanamycin/mL (Sigma Chemical
Company, St. Louis, Mo.). The M. smegmatis
(pYUB178::H37Rv) library was grown in Middlebrook
7H9 media (Difco) containing 10 µg kanamycin/mL and
0.05% (v/v) Tween 80 (Sigma) or on tryptic soy agar
(TSA) (Difco) containing 10 µg kanamycin/mL. E. coli
bacteria containing pHIP-based plasmids were grown in
LB containing 200 µg hygromycin/mL (Boehringer
Mannheim Biochemicals, Indianapolis, Ind.). M. smeg-
matis bacteria containing pHIP-based plasmids were
grown on TSA containing 50 µg hygromycin/mL or in
Middlebrook 7H9 media containing 50 µg hygromycin/
mL and 0.05% (v/v) Tween 80.
Table 1: Bacterial strains and plasmids used in this study.
Strain Relevant Characteristic/Use Source/Reference
E. coli XL 1 -Blue Laboratory strain Stratagene
M. smegmatis LR222 Laboratory strain [40]
M. smegmatis LR222 (pYUB178) pYUB178 [20]
M. smegmatis LR222 (pHIP1) xylE This study
M. smegmatis LR222 (pHIP2) Rv0365c This study
M. smegmatis LR222 (pHIP3) truncated Rv0365c This study
M. smegmatis LR222 (pHIP4) xylE, Rv0365c This study
M. smegmatis LR222 (pHIP5) Rv2233 This study
M. smegmatis LR222 (pHIP6) Rv2234 This study
M. smegmatis LR222 (pHIP7) Rv2235 This study
M. smegmatis LR222 (pHIP8) Rv2236c This study
M. smegmatis LR222 (pHIP9) Rv2237 This study
M. smegmatis LR222 (pHIP10) Rv2238c This study
M. smegmatis LR222 (pHIP11) Rv2239c This study
M. smegmatis LR222 (pHIP12) Rv2240c This study
M. smegmatis LR222 (pHIP13) Rv2233, Rv2234, Rv2235 This study
M. smegmatis LR222 (pHIP14) Rv2238c, Rv2239c, Rv2240c This study
M. smegmatis LR222 (pBPhin1) Rv0365c This study
M. smegmatis LR222 (pBPhin2) Rv2233, Rv2234, Rv2235 This study
Plasmids pTKmx xylE [32]
pYUB178 integrating cosmid [20]
pBPhin integrating plasmid [31]
pHIP integrating, hsp65 promoter This study
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ated by PCR from the M. tuberculosis H37Rv genome.
This PCR fragment was cloned into the BamHI site of
pBPhin [31] to generate pHIP. An amplicon carrying the
complete xylE ORF without the xylE promoter was gen-
erated by PCR of pTKmx [32], cleaved with BamHI, and
cloned into the BamHI site of pHIP downstream from
the hsp65 promoter to generate pHIP1.
DNA manipulations
All enzyme reactions were performed as recommended
by the manufacturers (GIBCO Bethesda Research Labo-
ratories, Inc., Gaithersburg, Md., New England Biolabs,
Beverly, Mass.). Cosmid DNA from E. coli was prepared
using the Qiagen Plasmid Maxi Kit (Qiagen, Valencia,
Calif.) according to manufacturer's instructions for low-
copy number plasmids. Wizard Plus Minipreps Kits
(Promega, Madison, Wis.) were used to isolate plasmid
DNA from E. coli strains. Mycobacterial genomic DNA
was isolated as previously described [33].
PCR
The primers used in this study and their sequences are
listed in Table 2. Primers were synthesized on a 381A
DNA synthesizer (Applied Biosystems, Foster City, Cal-
if.) at the Biotechnology Core Facility, National Center
for Infectious Diseases, CDC. Amplifications were done
using either a Perkin-Elmer Amp PCR System 2400 or
Model 480 DNA Thermal Cycler (Perkin-Elmer Cetus,
Norwalk, Conn). Each 100 µl PCR contained 3–5 µl of
template DNA, 5 µl of dimethyl sulfoxide (DMSO), and
90–92 µl of a reaction mixture (200 µM (each) deoxynu-
cleotide triphosphates, 1.0 µM (each) primer, 1.25 U of
AmpliTaq DNA Polymerase (Perkin-Elmer Cetus), 10
mM Tris hydrochloride pH 8.3, 50 mM KCl, 1.5 mM
MgCl2, and 0.01% (w/v) gelatin). Each sample was am-
plified for 30 cycles of denaturation at 94°C for 1.5 min-
utes, annealing at 60°C for 1.75 minutes, and extension
at 72°C for 2.5 minutes.
Table 2: PCR and sequencing primers used in this study. Underlined bases are restriction enzyme sites used in cloning. Bold bases rep-
resent either the start codon or stop codon of the gene being cloned.
Primer Sequence (5' to 3') Location/ Function
GGATAGATCTAGTTGCTGCAGCGT 5' end of HSP65 promoter
GAAGTGGATCCTCCGATCGGGGATG 3' end of HSP65 promoter
GACGGATCCATGACGTCATGAAC 5' end of xylE
GACGGATCCAAGCTTGCATGCC 3' end of xylE
CGGTGTCGCGGGCGGCGGCGTCG 5' end of sur2 probe
GATCGCATTATGAATCTGGCAAACC 3' end of sur2 probe
CAGGGATCCATCGCATTATGAATCTGGCAAACCG 5' end of Rv0365c
CAGGGATCCGTGTTACCCGAGTGAGCTGACC 3' end of Rv0365c
CAGGGATCCTTAATCCCAGAACGCCCCGAACACC sur2 end of truncated Rv0365c
GCGGCCGCAGATCTAGTTGCTGCAGCGTGAC 5' end of HSP65 promoter
GCGGCCGCGTGTTACCCGAGTGAGCTGACC 3' end of Rv0365c
GGATCCGACAGGCTAGGGCAGGATCGC 5' end of Rv0365c promoter
GACGGATCCGTTGGGCGATGAAACAGCTTG 5' end of Rv2233
GACGGATCCGGATCAGACACCTAGCGCCTC 3' end of Rv2233
GACAGATCTGTTGGGCGATGAAACAGCTTG 5' end of Rv2233
GACAGATCTGGCGCTAGGTGTCTGATCCGC 5' end of Rv2234
GACAGATCTGCATCAACTCGGTCCGTTCCG 3' end of Rv2234
GACGGATCCCCGAGTTGATGCCCCCGCC 5' end of Rv2235
GACGGATCCGGTTTACCGCCGGCGGCC 3' end of Rv2235
GACAGATCTGGTTTACCGCCGGCGGCC 3' end of Rv2235
GACGGATCCCTGCCGGAGTGTTTGCATCG 5' end of Rv2236c
GACGGATCCCCGCTACGGCCGCCGGC 3' end of Rv2236c
GACGGATCCCCAGGTCGATGCAAACACTCC 5' end of Rv2237
GACGGATCCGCTCTATCAGACGATTCGGCG 3' end of Rv2237
GAGGGATCCAAGCGCTGATGCTGAACGTCG 5' end of Rv2238c
GAGGGATCCCCCAAAACCTTAGGCCGTAAG 3' end of Rv2238c
GACGGATCCCGACGATAATGCCCATCGCG 5' end of Rv2239c
GACGGATCCGCATCAGCGCTTGCCAGCC 3' end of Rv2239c
GACGGATCCGCCAGATCGTGGCGGGCG 5' end of Rv2240c
GACGGATCCGCCTCAGAAGGCGGCCACG 3' end of Rv2240c
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The THP-1 cell line was obtained through the Biological
Products Branch of the National Center for Infectious
Diseases, CDC. THP-1 cells were grown in RPMI 1640
media (GIBCO BRL) containing 10% fetal calf serum
(FCS) (GIBCO BRL) at 37°C in 5% CO2 [21]. To differen-
tiate the THP-1 cells into macrophage-like cells, the cells
were treated with 10 µM phorbol myristate acetate
(PMA) (Sigma) as follows [21]. All PMA manipulations
were done under low light conditions. THP-1 cells were
harvested by centrifugation for 10 minutes at 228 × g,
and the pellet was resuspended in RPMI 1640/10% FCS/
10 µM PMA to give a cell density of approximately 1 × 106
THP-1 cells/mL. Three milliliters of the suspension was
added to each well of a six-well tissue culture plate (Cos-
tar, Corning, NY). The plates were incubated for 48
hours at 37°C in 5% CO2. The medium was removed from
each well, the attached cells were washed once with
RPMI 1640/10% FCS, and 3 ml of fresh RPMI 1640/10%
FCS was added. The cultures were incubated at 37°C in
5% CO2 for an additional 48 hours. Immediately prior to
infection, cells in each well were washed once with fresh
RPMI 1640/10% FCS.
Enrichment protocol
About 106 bacteria of the M. smegmatis
(pYUB178::H37Rv) library were inoculated into Middle-
brook 7H9 media containing 10 µg kanamycin/mL and
then were grown to midlog phase (OD600 ~ 0.3). The
bacteria were harvested by centrifugation for 1 minute at
16,000 × g and washed twice with RPMI 1640/10% FCS.
The bacteria were suspended in RPMI 1640/10% FCS at
5 × 108 bacteria/mL. The enrichment process was as fol-
lows (Figure 1): differentiated THP-1 macrophages were
infected by adding 3 mL of the bacterial suspension to
each well of a six-well plate. The multiplicity of infection
(MOI) was ~500 bacteria per THP-1 cell. The culture was
left at 37°C in 5% CO2 for 2 hours, which resulted in the
phagocytosis of about 10 bacteria per macrophage. After
the phagocytosis period, each well was washed twice
with RPMI 1640/10% FCS to remove free bacteria. To
kill any remaining extracellular bacteria, 3 mL of fresh
RPMI 1640/10% FCS/200 µg amikacin/mL (Sigma) was
added to each well. The infected THP-1 cultures were in-
cubated at 37°C for an additional 5 hours. Each well was
then washed twice with 3 mL of RPMI 1640/10% FCS,
and then 1 mL of 0.1% (v/v) Triton X-100 (Sigma) was
added to each well to lyse the macrophages. The wells
were scraped with a rubber policeman, and the lysates
were removed and diluted for plating on TSA containing
10 µg kanamycin/mL. After 3 days of incubation at 37°C,
bacteria from the resulting colonies were harvested, sus-
pended in Middlebrook 7H9 media containing 10 µg
kanamycin/mL and 0.05% (v/v) Tween 80, and pooled
for reinfection of THP-1 macrophages. The enrichment
process was done for a total of three cycles. After the
third round of enrichment, individual clones were isolat-
ed and analyzed.
Southern blots
PstI-digested genomic DNA was electrophoresed
through a 1.0% agarose gel, denatured, neutralized, and
transferred by capillary blotting to a Hybond -N+ mem-
brane (Amersham, Arlington Heights, IL). The blots
were hybridized to pYUB178 plasmid DNA labeled using
the ECL Direct Nucleic Acid Labeling and Detection Sys-
tem (Amersham). All hybridization and washing steps
were done at 42°C under either stringent (0.1 M NaCl) or
non-stringent conditions (0.5 M NaCl) according to kit
instructions.
Coinfection assay to measure survival
Coinfection assays were done as previously described
[22]. Briefly, separate cultures of recombinant and of
xylE-expressing bacteria were grown to midlog phase
(OD600 = ~0.3). The bacteria from each culture were
harvested by centrifugation for 1 minute at 16,000 × g,
washed twice with RPMI 1640/10% FCS, and resuspend-
ed in RPMI 1640/10% FCS at a concentration of 1.5 × 108
bacteria/mL. Equal volumes of the two bacterial suspen-
sions were mixed to produce a suspension containing a
1:1 ratio of recombinant-to-control bacteria. A portion of
the combined mixture was plated onto TSA plates to de-
termine the number of colony forming units (CFUs) of
each strain in the initial inoculum (the -2 hour time point
in figures). The bacterial suspension was diluted with
RPMI 1640/10% FCS to give approximately 5 × 107 bac-
teria/mL, and 3 mL was added to each well containing 1
× 106 THP-1 macrophages (MOI of 50 bacteria/macro-
phage). The cultures were incubated for 2 hours at 37°C
in 5% CO2 to allow phagocytosis to occur, and then each
well was washed twice with RPMI 1640/10% FCS to re-
move unphagocytosed bacteria. Typically, this results in
one phagocytosed bacterium per macrophage. To kill ex-
tracellular bacteria, 3 mL of RPMI 1640/10% FCS con-
taining 200 µg amikacin/mL was added to each well.
Cultures were incubated at 37°C in 5% CO2. At various
times, the medium was removed from each of three
wells, and 1 mL of 0.1% (v/v) Triton X-100 in H20 was
added to each well to lyse the macrophages. Each lysate
was diluted as necessary, and portions were plated on
TSA plates. The cultures which were assayed immediate-
ly after the addition of the media with amikacin serve to
measure of the number of phagocytosed viable bacteria;
the time at which these cultures were assayed was con-
sidered time zero (t0).
After a 3-day incubation at 37°C, the TSA plates from
each time point were stored overnight at 4°C. The follow-
ing day, the plates were sprayed with 0.5 M catechol (Sig-
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distinguish the xylE-expressing colonies (yellow) from
the recombinant colonies (white). Storing the plates
overnight at 4°C results in a stronger yellow color. To de-
termine the percent survival of a particular clone at time
point X, the number of CFUs at time × was divided by the
number of CFUs at to and multiplied by 100.
Recovery of the cloned M. tuberculosis genomic DNA frag-
ment
One µg of sur2 genomic DNA was digested with the re-
striction enzyme PstI then ethanol precipitated. The pre-
cipitated DNA was resuspended in 20 µL T4 ligase buffer
(GIBCO BRL) and then ligated for 2 hours at room tem-
perature with 0.5 units of T4 ligase (GIBCO BRL). The li-
gation mixture was electroporated into electrocompetent
E. coli, and kanamycin-resistant transformants were iso-
lated. After sequencing the M. tuberculosis H37Rv insert
in the recovered plasmid, PCR primers were designed to
amplify a product containing a portion of the cloned M.
tuberculosis H37Rv genomic DNA. The PCR product was
used as a probe for colony blots to find cosmids in the E.
coli (pYUB178::H37Rv) library carrying at least a portion
of the cosmid integrated in the sur2 clone.
A plasmid carrying a portion of the M. tuberculosis
H37Rv insert in the sur3 clone was isolated in a similar
manner from a BamHI digest of sur3 genomic DNA. The
BamHI/EcoRI fragment of the M. tuberculosis H37Rv
insert of the recovered plasmid was used as a probe in
colony blots to find cosmids in the E. coli
(pYUB178::H37Rv) library.
Colony blots
Portions of the E. coli (pYUB178::H37Rv) cosmid library
were plated on LB agar containing 50 µg kanamycin/mL,
and colony blots were performed with the ECL Direct
Nucleic Acid Labeling & Detection System (Amersham)
according to manufacturer's instructions. Colonies hy-
bridizing with the probe of interest were removed as
plugs and incubated in LB containing 50 µg kanamycin/
mL for approximately 30 minutes at 37°C. Dilutions of
this culture were plated on LB agar containing 50 µg kan-
amycin/mL to give well-separated colonies. Colony blots
were performed and positive clones were selected for
further study.
Subcloning ORFs into pHIP and pBPhin
Unless otherwise stated, all M. tuberculosis open-read-
ing frames (ORFs) were generated by PCR from M. tu-
berculosis H37Rv genomic DNA as full-length ORFs
without their natural promoters. The PCR primers (Ta-
ble 2) were designed to contain restriction enzyme sites
for cloning of the amplicon into the pHIP vector down-
stream of the hsp65 promoter as well as the eight base-
pairs (bp) upstream of the start codon of the gene being
cloned. Because the hsp65 promoter in pHIP contains a
ribosome binding site (rbs), the spacing between the rbs
and the start codon of the cloned gene is about the same
in these constructs as the spacing between the rbs and
the start codon of the hsp65 gene in wild-type M. tuber-
culosis.
A truncated form of the Rv0365c gene was generated by
PCR to contain 969 bp of the 970 bp of the truncated
ORF present in the sur2 clone followed immediately by a
stop codon. This fragment was BamHI-digested and
ligated to BamHI-digested pHIP to form pHIP3. An am-
plicon containing the hsp65 promoter and full-length
Rv0365c gene was generated by PCR amplification of the
pHIP2 plasmid. This amplicon was NotI-digested and
cloned into the NotI site of the pHIP1 plasmid containing
the xylE gene to generate pHIP4. Plasmid pBPhin1 was
constructed by ligating a BamHI-digested PCR fragment
containing the Rv0365c gene plus 24 bp located up-
stream of it to BamHI-digested pBPhin. Plasmid pHIP13
was created by cloning a BglII-digested PCR fragment
containing Rv2233,Rv2234, and Rv2235 into the Bam-
HI site downstream of the hsp65 promoter of pHIP. Plas-
mid pHIP14 was created by cloning a BamHI-digested
PCR fragment containing Rv2238c, Rv2239c, and
Rv2240c into the BamHI site downstream of the hsp65
promoter of pHIP such that Rv2240c was proximal to
the hsp65 promoter. Plasmid pBPhin2 was created by li-
gating the BglII-digested Rv2233-Rv2235 fragment into
the BamHI site of pBPhin.
Electroporation
All electroporations were conducted using a Bio-Rad
Pulse Controller (Bio-Rad, Hercules, Calif). Preparation
and electroporation of competent E. coli XL 1-Blue cells
were done according to Bio-Rad instructions. Competent
M. smegmatis LR222 cells were prepared and electropo-
rated as described by Jacobs et al. [34].
DNA sequencing
All sequencing reactions were prepared with the Applied
Biosystems, Inc. (ABI) PRISM Dye Terminator Cycle Se-
quencing Ready Reaction Kit (Applied Biosystems) ac-
cording to the manufacturer. All sequencing was
conducted using an ABI 373 DNA Sequencing System
(Applied Biosystems).
Statistical analysis
Results were analyzed by the two-sample T test.
DNA and protein homology analyses
DNA and protein database searches were performed us-
ing the BLAST services (blastn, blastp, and psi-blast) at
the National Center for Biotechnology Information (NC-
BMC Microbiology 2001, 1:26 http://www.biomedcentral.com/1471-2180/1/26BI) [35,36] and the genomes site at The Institute for Ge-
nomic Research  [http://www.tigr.org] . Protein
domain/motif searches were performed using PSI-
BLAST [37], and CD-Search (RPS-BLAST) [36] at NCBI
and the SMART utility at the European Molecular Biolo-
gy Laboratories [38,39].
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